Shares of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) rise 0.3%

0

Fresenius Medical Care AG & Co. KGaA (New York Stock Exchange: FMSGet a rating) the stock price jumped 0.3% during Monday’s trading. The stock traded as high as $26.83 and last traded at $26.80. 2,655 shares were traded during the midday session, down 99% from the average session volume of 495,857 shares. The stock previously closed at $26.73.

Several research companies have recently commented on the FMS. Oddo Bhf upgraded Fresenius Medical Care AG & Co. KGaA from a “neutral” rating to an “outperforming” rating and set a target price of €72.00 ($77.42) on the stock in a report of research from Tuesday, March 1. Credit Suisse Group cut its price target on Fresenius Medical Care AG & Co. KGaA from €66.00 ($70.97) to €61.00 ($65.59) in a Tuesday, March 1 research report . JPMorgan Chase & Co. raised its price target on Fresenius Medical Care AG & Co. KGaA from €48.70 ($52.37) to €51.00 ($54.84) ​​and assigned the stock a “underweight” rating in a Thursday, May 5, research report. StockNews.com began covering Fresenius Medical Care AG & Co. KGaA in a research report on Tuesday, May 10. They set a “buy” rating on the stock. Finally, Berenberg Bank reduced its price target on Fresenius Medical Care AG & Co. KGaA from €84.90 ($91.29) to €83.40 ($89.68) in a Thursday, March 17 research report . Two equity research analysts gave the stock a sell rating, six gave the company a hold rating and four gave the company a buy rating. Based on data from MarketBeat.com, Fresenius Medical Care AG & Co. KGaA has an average rating of “Hold” and an average target price of $53.71.

The stock has a fifty-day simple moving average of $31.10 and a two-hundred-day simple moving average of $31.94. The stock has a market capitalization of $15.67 billion, a price/earnings ratio of 15.27, a P/E/G ratio of 1.07 and a beta of 1.17. The company has a debt ratio of 0.51, a quick ratio of 0.93 and a current ratio of 1.26.

Fresenius Medical Care AG & Co. KGaA (New York Stock Exchange: FMSGet a rating) last reported results on Wednesday, May 4. The company reported earnings per share of $0.38 for the quarter, beating consensus analyst estimates of $0.30 by $0.08. Fresenius Medical Care AG & Co. KGaA achieved a return on equity of 6.99% and a net margin of 4.91%. The company posted revenue of $5.10 billion for the quarter, versus a consensus estimate of $4.97 billion. Stock analysts expect Fresenius Medical Care AG & Co. KGaA to post earnings per share of 1.99 for the current fiscal year.

The company also recently declared an annual dividend, which was paid on Friday, May 27. Shareholders of record on Monday, May 16 received a dividend of $0.7093. This represents a dividend yield of 3.4%. The ex-dividend date was Friday, May 13. The payout rate of Fresenius Medical Care AG & Co. KGaA is 28.00%.

Institutional investors and hedge funds have recently changed their positions in the company. Commonwealth Equity Services LLC increased its stake in the shares of Fresenius Medical Care AG & Co. KGaA by 6.4% in the 4th quarter. Commonwealth Equity Services LLC now owns 13,583 shares of the company valued at $440,000 after acquiring 817 additional shares in the last quarter. Atlas Capital Advisors LLC increased its stake in the shares of Fresenius Medical Care AG & Co. KGaA by 27.1% in the 4th quarter. Atlas Capital Advisors LLC now owns 9,266 shares of the company valued at $301,000 after acquiring 1,973 additional shares in the last quarter. UMB Bank NA MO bought a new position in Fresenius Medical Care AG & Co. KGaA during Q4 for a value of $192,000. Legacy Wealth Asset Management LLC increased its position in Fresenius Medical Care AG & Co. KGaA by 283.2% during the 4th quarter. Legacy Wealth Asset Management LLC now owns 36,892 shares of the company worth $1,198,000 after purchasing an additional 27,264 shares in the last quarter. Finally, Alan B. Lancz & Associates Inc. bought a new position in Fresenius Medical Care AG & Co. KGaA during Q4 at a value of $196,000. Institutional investors hold 4.73% of the company’s shares.

About Fresenius Medical Care AG & Co. KGaA (New York Stock Exchange: FMS)

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure.

Featured Articles



Get news and reviews for Fresenius Medical Care AG & Co. KGaA Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com’s free daily email newsletter .

Share.

Comments are closed.